Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Teresa Sandri

Showing results (1-10 of 88) with videos related to

Pageof 9
Sort By:
Progress in Cardiovascular Diseases|August 24, 2010
Role of biomarkers in chemotherapy-induced cardiotoxicityDaniela Cardinale, Maria Teresa Sandri
Methods (San Diego, Calif.)|February 2, 2010
Circulating tumour cells in clinical practice: Methods of detection and possible characterizationMarianna Alunni-Fabbroni, Maria Teresa Sandri
Giornale Italiano Di Cardiologia (2006)|November 30, 2006
[Biochemical markers for predicting chemotherapy-induced cardiotoxicity: systematic review of the literature and recommendations for use]Alberto Dolci, Roberto Dominici, Daniela Cardinale, et al.
Journal of Clinical Microbiology|June 17, 2016
The BD Onclarity HPV Assay on Samples Collected in SurePath Medium Meets the International Guidelines for Human Papillomavirus Test Requirements for Cervical ScreeningDitte Ejegod, Fabio Bottari, Helle Pedersen, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|January 19, 2017
The clinical implementation of primary HPV screeningLuciano Mariani, Sarah Igidbashian, Maria Teresa Sandri, et al.
Journal of Lower Genital Tract Disease|November 13, 2019
Clinical Utility of Human Papillomavirus Genotyping in Cervical Cancer Screening: A Systematic ReviewJesper H Bonde, Maria-Teresa Sandri, Devin S Gary, et al.
European Journal of Cancer (Oxford, England : 1990)|September 14, 2010
ABO blood group and cancerSimona Iodice, Patrick Maisonneuve, Edoardo Botteri, et al.
Expert Review of Molecular Diagnostics|January 17, 2017
Using biomarkers to predict and to prevent cardiotoxicity of cancer therapyDaniela Cardinale, Gina Biasillo, Michela Salvatici, et al.
Journal of Women'S Health (2002)|March 1, 2011
Self-collected human papillomavirus testing acceptability: comparison of two self-sampling modalitiesSarah Igidbashian, Sara Boveri, Noemi Spolti, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|July 31, 2013
Comparison of hybrid capture 2 High-Risk HPV results in the low positive range with cobas® HPV Test results from the ATHENA studyArundhati Rao, Maria Teresa Sandri, Mario Sideri, et al.
Pageof 9

Showing results (1-10 of 88) with videos related to

Sort By:
Pageof 9
Progress in Cardiovascular Diseases|August 24, 2010
Role of biomarkers in chemotherapy-induced cardiotoxicityDaniela Cardinale, Maria Teresa Sandri
Methods (San Diego, Calif.)|February 2, 2010
Circulating tumour cells in clinical practice: Methods of detection and possible characterizationMarianna Alunni-Fabbroni, Maria Teresa Sandri
Giornale Italiano Di Cardiologia (2006)|November 30, 2006
[Biochemical markers for predicting chemotherapy-induced cardiotoxicity: systematic review of the literature and recommendations for use]Alberto Dolci, Roberto Dominici, Daniela Cardinale, et al.
Journal of Clinical Microbiology|June 17, 2016
The BD Onclarity HPV Assay on Samples Collected in SurePath Medium Meets the International Guidelines for Human Papillomavirus Test Requirements for Cervical ScreeningDitte Ejegod, Fabio Bottari, Helle Pedersen, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|January 19, 2017
The clinical implementation of primary HPV screeningLuciano Mariani, Sarah Igidbashian, Maria Teresa Sandri, et al.
Journal of Lower Genital Tract Disease|November 13, 2019
Clinical Utility of Human Papillomavirus Genotyping in Cervical Cancer Screening: A Systematic ReviewJesper H Bonde, Maria-Teresa Sandri, Devin S Gary, et al.
European Journal of Cancer (Oxford, England : 1990)|September 14, 2010
ABO blood group and cancerSimona Iodice, Patrick Maisonneuve, Edoardo Botteri, et al.
Expert Review of Molecular Diagnostics|January 17, 2017
Using biomarkers to predict and to prevent cardiotoxicity of cancer therapyDaniela Cardinale, Gina Biasillo, Michela Salvatici, et al.
Journal of Women'S Health (2002)|March 1, 2011
Self-collected human papillomavirus testing acceptability: comparison of two self-sampling modalitiesSarah Igidbashian, Sara Boveri, Noemi Spolti, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|July 31, 2013
Comparison of hybrid capture 2 High-Risk HPV results in the low positive range with cobas® HPV Test results from the ATHENA studyArundhati Rao, Maria Teresa Sandri, Mario Sideri, et al.
Pageof 9